Health News
Two Sisters Help Understand One Disease
It's well known that cancer can be passed between a donor and recipient during a transplant operation. One such exchange has actually advanced the scientific understanding of lymphoma.
New Lymphoma Bull's-Eye
It's the most aggressive blood cancer. Unfortunately, Diffuse Large B-Cell Lymphoma ( DLBCL ) is also the most common form of lymphoma in adults. But there is some good news - researchers may have a new target for treating this disease.
Horizon Brightening for Lymphoma
Just because something works in mice, doesn't mean it will work in humans. That being said, a new mouse study holds out hope for a new therapy for lymphoma.
Researchers have identified two molecules that are better killers of lymphoma than existing therapies. These findings, if they hold true for humans, could lead to new cancer therapies.
Ask your doctor about the very latest science relating to lymphoma therapies.
First author Hye-Ra Lee, Ph.D., a research fellow in the Department of Molecular Microbiology & Immunology at the Keck School of Medicine of the University of So...
Advanced Treatment for Lymphoma
You learn you have a rare cancer located at the back of your throat. Traditional therapies might affect your ability to eat, speak and swallow. A new study shows advanced radiation therapy is effective in treating this type of cancer without harsh side effects.
Overcoming Transplant Rejection
Blood cancers - leukemia, lymphoma and myeloma - interfere with the body's ability to make healthy blood cells. Scientists may have discovered a new way to treat these diseases in ways that offer new hope.
The Risks of Rural Life
It seems so idyllic - the farm life does. Yet new research finds that children who grew up on a livestock farm are at greater risk for developing certain types of cancer.
FDA Drug Safety Communication: TNF blockers
The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as h epatosplenic T-Cell lymphoma or HSTCL ), primarily in adolescents and young adults being treated for Crohn’s disease and ulcerative colitis with medicines known as tumor necrosis factor ( TNF ) blockers, as well as with azathioprine , and/or mercaptopurine .
Crohn's disease and ulcerative colitis cause inflammation of the digestive system. Common symptoms are pain in the abdomen, cramps, and diarrhea. Bleeding from the rectum, wei...
ODAC Recommends Accelerated Approval of new Lymphoma Drug
The Oncologic Drugs Advisory Committee ( ODAC ) to the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend that the FDA grant accelerated approval of Adcetris ( brentuximab vedotin ).
"Turned Off" in Human Tumors
Researchers have gained new insights into one of the most aggressive tumors affecting humans, Burkitt's lymphoma cancer. There may be new ways of treating this painful and deadly disease with a new mechanism responsible for breaking down the genetic protections against tumors.
Follow-up Therapy Shown to Improve Lymphoma Survival Rates
Follicular lymphoma patients fare better after receiving two years of rituximab-maintenance therapy following immunochemotherapy, according to a new study.